Hemanth Kumar

Hemanth Kumar is a News Editor for NRi Digital.

All articles by Hemanth Kumar

  1. Merck and Skyhawk Therapeutics sign collaboration agreement

    Merck has signed a strategic collaboration agreement with Skyhawk Therapeutics to use its SkySTAR technology to develop drug candidates for…
    Read More…

    9 Jul
  2. Eisai forms PROTACs research collaboration

    Eisai has formed a research collaboration to support oncology drug discovery using proteolysis targeting chimeras (PROTAC), which comprise two covalently linked…
    Read More…

    8 Jul
  3. Roche subsidiary Genentech to acquire Jecure Therapeutics

    Swiss firm Roche Group’s affiliate Genentech has agreed to acquire US biotechnology company Jecure Therapeutics to strengthen its position in…
    Read More…

    28 Nov
  4. C4X Discovery launches drug discovery partnership with LifeArc

    C4X Discovery has formed a discovery partnership with British medical research charity LifeArc to collaborate on the development of small…
    Read More…

    27 Nov
  5. Fluidic Analytics gains funding for lab-tools products launch

    UK-based Fluidic Analytics has raised $31m in the latest round of financing led by European venture capital fund Draper Esprit….
    Read More…

    26 Nov
  6. EIB to fund F2G Biotech’s anti-fungal drug research project

    The European Investment Bank (EIB) has provided €24m in funding to Austria’s F2G Biotech to support the latter’s research and…
    Read More…

    23 Nov
  7. ESMO launches new partnership to improve Asian-European collaboration

    The European Society for Medical Oncology (ESMO) has unveiled a new partnership to improve collaboration and information sharing between European…
    Read More…

    22 Nov
  8. Takeda gets conditional EC approval for $62bn Shire acquisition

    Takeda Pharmaceutical has received a conditional approval from the European Commission (EC) for the $62bn proposed acquisition of Irish biopharmaceutical…
    Read More…

    21 Nov
  9. Merck and Palantir to form JV to advance cancer research

    Merck has signed a non-binding term sheet to establish a joint venture (JV) with data analytics firm Palantir Technologies to…
    Read More…

    20 Nov
  10. Mundipharma acquires rights for Invossa osteoarthritis therapy in Japan

    Mundipharma has signed a multi-year agreement for up to $600m with Kolon Life Sciences to secure the exclusive rights for…
    Read More…

    19 Nov
Close
Close
Close

Go Top